CorMedix (CRMD) Other financing activities (2012 - 2025)

CorMedix has disclosed Other financing activities across 7 years of filings, most recently posting -$94377.0 for Q4 2025.

• Other financing activities for Q4 2025 came in at -$94377.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was $3.2 million (changed N/A YoY), and the FY2025 annual result was $188000.0, changed N/A from the prior year.
• Other financing activities came in at -$94377.0 for Q4 2025 at CorMedix, down from $49192.0 in the prior quarter.
• In the past five years, Other financing activities ranged from a high of $2.2 million in Q1 2023 to a low of -$94377.0 in Q4 2025.
• The 3-year median for Other financing activities is $1.1 million (2022), against an average of $906733.3.
• Peak annual rise in Other financing activities reached 94.71% in 2023, while the deepest fall reached 1.52% in 2023.
• CorMedix's Other financing activities stood at $1.1 million in 2022, then dropped by 1.52% to $1.1 million in 2023, then tumbled by 108.93% to -$94377.0 in 2025.
• The last three Other financing activities figures came in at -$94377.0 (Q4 2025), $49192.0 (Q3 2025), and $1.1 million (Q2 2023), per Business Quant data.